From Optimal Design of Experiment to Safe System Identification in Type 2 Diabetes

Sarah Ellinor Engell*, Henrik Bengtsson, Jeppe Sturis, Dimitri Boiroux, John Bagterp Jørgensen*

*Corresponding author for this work

Research output: Contribution to journalConference articleResearchpeer-review

23 Downloads (Pure)

Abstract

Model-based design of experiment (MBDoE) provides a framework to collect informative data for system identification. However, a parametric and structural mismatch between the design model and the underlying physical system can lead to hazardous experiments in safety critical systems. In this work, we present a method to safely improve system identification based on insights from a model-based optimal experimental design. From a visual inspection of a MBDoE, we select an approximated output curve fulfilling system constraints as a reference for the physical system. To avoid open-loop implementation of the MBDoE, we use our approximated reference together with a reference-tracking controller to collect experimental data in closed-loop. In this type 2 diabetes (T2D) case study, the proposed design method is safe and provides informative experimental data for system identification.

Original languageEnglish
Book seriesIFAC-PapersOnLine
Volume56
Issue number2
Pages (from-to)9654-9659
DOIs
Publication statusPublished - 2023
Event22nd IFAC World Congress
- Pacific Convention Plaza Yokohama, Yokohama, Japan
Duration: 9 Jul 202314 Jul 2023
Conference number: 22

Conference

Conference22nd IFAC World Congress
Number22
LocationPacific Convention Plaza Yokohama
Country/TerritoryJapan
CityYokohama
Period09/07/202314/07/2023
SponsorAzbil Corporation, Fujita Corporation, Hitachi, Ltd., Kumagai Gumi Co., Ltd., The Society of Instrument and Control Engineers (SICE)

Keywords

  • Artificial Pancreas
  • Diabetes
  • Insulin
  • Optimal Experimental Design
  • Simulation
  • System Identification

Fingerprint

Dive into the research topics of 'From Optimal Design of Experiment to Safe System Identification in Type 2 Diabetes'. Together they form a unique fingerprint.

Cite this